col blocks we are bridge builder col blocks
COVID Antworten in den wissenschaftlichen Zeitschriften der Welt


34 Ergebisse       Seite 1

 [1] 
Wiley: Proteins Structure Function and Bioinformatics
  Original Artikel Datum Titel Autoren   Alle Autoren
1 [GO] 2024―Mrz―09 Allosteric pathways of SARS and SARS-CoV-2 spike protein identified by neural relational inference Yao Hu, Mingwei Li, Qian Wang
2 [GO] 2024―Jan―06 Mechanistic study of the transmission pattern of the SARS-CoV-2 omicron variant Ke An, Xianzhi Yang, Mengqi Luo, Junfang Yan, Peiyi Xu, Honghui Zhang, et al. (+4)
3 [GO] 2023―Nov―06 A structural analysis of the nsp9 protein from the coronavirus MERS CoV reveals a conserved RNA binding interface Gayathri Mani, Serene El-Kamand, Bing Wang, David L. Baker, Sandro F. Ataide, Irina Artsimovitch, et al. (+2)
4 [GO] 2023―Jul―06 Conformational response to ligand binding of TMPRSS2, a protease involved in SARS-CoV-2 infection: Insights through computational modeling Giorgia Frumenzio, Balasubramanian Chandramouli, Neva Besker, Alessandro Grottesi, Carmine Talarico, Francesco Frigerio, et al. (+2)
5 [GO] 2023―Jul―06 SARS-CoV-2 main protease mutation analysis via a kinematic method Xiyu Chen, Sigrid Leyendecker, Henry van den Bedem
6 [GO] 2023―Jun―08 An efficient computational protocol for template-based design of peptides that inhibit interactions involving SARS-CoV-2 proteins Akshay Chenna, Wajihul Hasan Khan, Rozaleen Dash, Saurabh Saraswat, Archana Chugh, Anurag S. Rathore, Gaurav Goel
7 [GO] 2023―Apr―20 Dynamical changes of SARS-CoV -2 spike variants in the highly immunogenic regions impact the viral antibodies escaping Lorenzo Di Rienzo, Mattia Miotto, Fausta Desantis, Greta Grassmann, Giancarlo Ruocco, Edoardo Milanetti
8 [GO] 2023―Mrz―13 SARS-CoV -2 neutralizing antibody epitopes are overlapping and highly mutated which raises the chances of escape variants and requires development of broadly reactive vaccines Jeswin Joseph, Sukhada Darpe, Grishma Kulkarni, V. Stalin Raj
9 [GO] 2023―Jan―11 A novel consensus-based computational pipeline for screening of antibody therapeutics for efficacy against SARS-CoV-2 variants of concern including Omicron variant Naveen Kumar, Rahul Kaushik, Kam Y. J. Zhang, Vladimir N. Uversky, Upasana Sahu, Richa Sood, Sandeep Bhatia
10 [GO] 2022―Dez―24 Atomic-Level Thermodynamics Analysis of the Binding Free Energy of SARS-CoV -2 Neutralizing Antibodies Jihyeon Lee, Chaok Seok, Sihyun Ham, Song-Ho Chong
11 [GO] 2022―Nov―02 Predicting DNA -binding protein and Coronavirus protein flexibility using protein dihedral angle and sequence feature Wei Wang, Xili Su, Dong Liu, HongJun Zhang, XianFang Wang, Yun Zhou
12 [GO] 2022―Sep―16 De novo design and Rosetta-based assessment of high-affinity antibody variable regions (Fv) against the SARS-CoV -2 spike receptor binding domain ( RBD ) Veda Sheersh Boorla, Ratul Chowdhury, Ranjani Ramasubramanian, Brandon Ameglio, Rahel Frick, Jeffrey J. Gray, Costas D. Maranas
13 [GO] 2022―Mai―14 Molecular Interactions and Inhibition of the SARS-CoV-2 Main Protease by a Thiadiazolidinone Derivative Jacob Andrzejczyk, Katarina Jovic, Logan M. Brown, Valerie G. Pascetta, Krisztina Varga, Harish Vashisth
14 [GO] 2022―Apr―05 Integrated bioinformatics-cheminformatics approach towards locating pseudo-potential antiviral marine alkaloids against SARS-CoV-2-Mpro Shasank S. Swain, Satya R. Singh, Alaka Sahoo, Pritam Kumar Panda, Tahziba Hussain, Sanghamitra Pati
15 [GO] 2022―Feb―04 Structure and dynamics of the SARS-CoV -2 envelope protein monomer Alexander Kuzmin, Philipp Orekhov, Roman Astashkin, Valentin Gordeliy, Ivan Gushchin
16 [GO] 2021―Dez―08 Isolation and characterization of ACE-I inhibitory peptides from ribbonfish for a potential inhibitor of the main protease of SARS-CoV-2; an in-silico analysis. Undiganalu Gangadharappa Yathisha, Mahendra Gowdru Srinivasa, Revana Siddappa B. C., Shankar P. Mandal, Sheshagiri R. Dixit, G. V. Pujar, Mamatha BS
17 [GO] 2021―Nov―15 Boosting the analysis of protein interfaces with Multiple Interface String Alignments: illustration on the spikes of coronaviruses S. Bereux, B. Delmas, F. Cazals
18 [GO] 2021―Nov―11 Elucidating important structural features for the binding affinity of spike - SARS-CoV -2 neutralizing antibody complexes Divya Sharma, Puneet Rawat, Vani Janakiraman, M. Michael Gromiha
19 [GO] 2021―Nov―05 In Silico Prediction of SARS-CoV -2 Main Protease Cleavage Sites Zheng Rong Yang
20 [GO] 2021―Okt―20 Conformational variability of loops in the SARS-CoV -2 spike protein Samuel W. K. Wong, Zongjun Liu
21 [GO] 2021―Okt―12 Crystal-Structures-Guided Design of Fragment-Based Drugs for Inhibiting the Main Protease of SARS-CoV -2 Binquan Luan, Tien Huynh
22 [GO] 2021―Sep―28 Evolution of the SARS-CoV -2 proteome in three dimensions ( 3D ) during the first six months of the COVID -19 pandemic Joseph H. Lubin, Christine Zardecki, Elliott M. Dolan, Changpeng Lu, Zhuofan Shen, Shuchismita Dutta, et al. (+58)
23 [GO] 2021―Aug―31 Modeling SARS-CoV2 proteins in the CASP -commons experiment Andriy Kryshtafovych, John Moult, Wendy M. Billings, Dennis Della Corte, Krzysztof Fidelis, Sohee Kwon, et al. (+4)
24 [GO] 2021―Aug―10 Molecular Dynamics Analysis of a Flexible Loop at the Binding Interface of the SARS-CoV -2 Spike Protein Receptor-Binding Domain Jonathan K. Williams, Baifan Wang, Andrew Sam, Cody L. Hoop, David A. Case, Jean Baum
25 [GO] 2021―Aug―09 A distinct ssDNA / RNA binding interface in the Nsp9 protein from SARS-CoV -2 Serene El-Kamand, Mar-Dean Du Plessis, Natasha Breen, Lexie Johnson, Samuel Beard, Ann H. Kwan, et al. (+3)
26 [GO] 2021―Aug―01 An In silico scientific basis for LL -37 as a therapeutic for Covid-19 Kiran Bharat Lokhande, Tanushree Banerjee, K. Venkateswara Swamy, Payel Ghosh, Manisha Deshpande
27 [GO] 2021―Mai―19 Structures of MERS-CoV Macro Domain in Aqueous Solution with Dynamics: Impacts of Parallel Tempering Simulation Techniques and CHARMM36m and AMBER99SB Force Field Parameters Ibrahim Yagiz Akbayrak, Sule Irem Caglayan, Serdar Durdagi, Lukasz Kurgan, Vladimir N. Uversky, Burak Ulver, et al. (+4)
28 [GO] 2021―Mai―13 Comparative Protein Structure Network Analysis on 3CL pro from SARS-CoV -1 and SARS-CoV -2 Surabhi Lata, Mohd. Akif
29 [GO] 2021―Mai―11 ACE2-Based Decoy Receptors for SARS Coronavirus 2 Wenyang Jing, Erik Procko
30 [GO] 2021―Apr―24 Tackling Covid-19 using disordered-to-order transition of residues in the spike protein upon angiotensin-converting enzyme 2 binding Dhanusha Yesudhas, Ambuj Srivastava, Masakazu Sekijima, M. Michael Gromiha
31 [GO] 2021―Apr―17 Molecular basis for higher affinity of SARS-CoV -2 spike RBD for human ACE2 receptor Julián M. Delgado, Nalvi Duro, David M. Rogers, Alexandre Tkatchenko, Sagar A. Pandit, Sameer Varma
32 [GO] 2020―Nov―19 Why are ACE2 binding coronavirus strains SARS-CoV / SARS-CoV -2 wild and NL63 mild? Puneet Rawat, Sherlyn Jemimah, P K Ponnuswamy, M Michael Gromiha
33 [GO] 2020―Jul―14 omputer modelling of a potential agent against SARS-Cov -2 ( COVID -19) protease Arthur M. Lesk, Arun S. Konagurthu, Lloyd Allison, Maria Garcia Banda, Peter J. Stuckey, David Abramson
34 [GO] 2020―Jun―16 Evolutionary relationships and sequence-structure determinants in human SARS coronavirus-2 spike proteins for host receptor recognition Lalitha Guruprasad
 [1] 

34 Ergebisse       Seite 1


[de][en]

Letzte Änderung 2023―Okt―27 12:08:13 UTC

© Daten-Quadrat 2022       Done in 0.003 sec